- Home
- FLO vs KURA Comparison
FLO vs KURA Comparison
Compare FLO & KURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FLO | KURA |
|---|---|---|
| Founded | 1919 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Packaged Foods | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.1B |
| IPO Year | 2000 | 2015 |
Fundamental Metrics
Financial Performance| Metric | FLO | KURA |
|---|---|---|
| Price | $5.98 | $9.36 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 5 | 16 |
| Target Price | $7.40 | ★ $31.85 |
| AVG Volume (30 Days) | ★ 6.7M | 1.6M |
| Earning Date | 11-05-2026 | 11-03-2026 |
| Dividend Yield | ★ 8.18% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.39 | N/A |
| Revenue | ★ $5,256,479,000.00 | $67,482,000.00 |
| Revenue This Year | N/A | $42.46 |
| Revenue Next Year | N/A | $116.76 |
| P/E Ratio | $15.71 | ★ N/A |
| Revenue Growth | 3.00 | ★ 25.24 |
| 52 Week Low | $5.40 | $7.36 |
| 52 Week High | $13.11 | $13.90 |
Technical Indicators
Market Signals| Indicator | FLO | KURA |
|---|---|---|
| Relative Strength Index (RSI) | 45.54 | 28.29 |
| Support Level | $5.40 | $8.45 |
| Resistance Level | $8.94 | $9.82 |
| Average True Range (ATR) | 0.21 | 0.43 |
| MACD | 0.08 | -0.14 |
| Stochastic Oscillator | 57.87 | 13.52 |
Price Performance
Historical ComparisonAbout FLO Flowers Foods Inc.
Flowers Foods Inc operates as a producer and marketer of packaged bakery foods in the United States. Its principal products include breads, buns, rolls, snack items (bars, cakes, cookies, and crackers), bagels, English muffins, tortillas, and baking mixes. These products are sold under the brand names Nature's Own, Dave's Killer Bread (DKB), Canyon Bakehouse, Simple Mills, Wonder, and Tastykake. The company derives the majority of its revenue from the sales of its bakery products.
About KURA Kura Oncology Inc.
Kura Oncology Inc is a biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for the treatment of cancer. The company develops small-molecule medicines designed to target cancer signaling pathways in oncology and hematology. Its pipeline includes menin inhibitor ziftomenib for the treatment of acute myeloid leukemia and other hematologic malignancies, as well as additional product candidates such as KO-7246 and darolifarnib being evaluated for solid tumors and other diseases.